news 
John Fetterman, the Democratic candidate running for the Senate in Pennsylvania, has announced his support for Medicare covering GLP-1 medications, citing the need for affordable healthcare options.
Fetterman’s decision comes as part of a broader push by him to promote accessible and cost-effective healthcare solutions. The Democratic candidate believes that Medicare should play a crucial role in addressing this issue, providing coverage for essential medications such as GLP-1s.
In his statement, Fetterman emphasized the importance of putting an end to the ongoing struggle many Americans face when it comes to accessing lifesaving medication at a reasonable cost.
“This should be simple,” he said. “Our government should prioritize making lifesaving medication accessible and affordable. Mr. Biden’s previous attempt was the type of common-sense solution that politicians in D.C. talk about all the time but rarely put into action. I urge the Trump administration and Mr. Kennedy to reverse course and make this rule a reality.”
GLP-1 medications have been the subject of controversy recently, with the Trump administration previously deciding against Medicare coverage due to concerns over their high cost and potential impact on Medicaid costs.
Fetterman’s stance is in line with his commitment to improving healthcare for all Americans.
Source: https://thehill.com/policy/healthcare/5240818-fetterman-medicare-medicaid-ozempic-wegovy-glp-1-weight-loss-meds/
